AstraZeneca, drugmakers release promising cancer data
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be …
Biotech and Pharmaceuticals
Pfizer, Merck, J&J to release cancer drug data
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be …
FDA approves Moderna RSV vaccine for seniors
The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 …
Ro launches GLP-1 supply tracker to help patients navigate shortages
GLP-1 Supply Tracker from Ro. Courtesy: Ro Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called …
This up-and-coming cancer treatment could be a $25 billion market opportunity
Skynesher | E+ | Getty Images Big pharma is betting billions on an up-and-coming class of cancer treatments that some on Wall Street are calling a “massive opportunity.” It’s called …
Pfizer announces new cost cutting program
Exterior view of the Pfizer headquarters building in New York City on Jan. 29, 2023. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched …
Eli Lilly, Novo Nordisk develop weekly insulin
A patient injects herself with an insulin pen. Guido Krzikowski | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them …
FDA approves Amgen small cell lung cancer treatment
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly …
1 in 8 adults have taken GLP-1s like Ozempic: survey
Rebekah Carl poses with her prescription of Wegovy in New Columbia, Pennsylvania, U.S., November 13, 2023. Hannah Beier | Reuters Think a friend or colleague should be getting this newsletter? …
OpenAI is first company to be No. 1 on Disruptor 50 two years in a row
It’s a first for the annual CNBC Disruptor 50 list: a company landing at No. 1 for the second year in a row. Perhaps no surprise, that company is OpenAI. …